INSERM, Pathophysiology of Psychiatric Disorders, CPN, U894, Sainte-Anne Hospital, Paris F-75014, France.
Trends Mol Med. 2009 Dec;15(12):562-70. doi: 10.1016/j.molmed.2009.10.001. Epub 2009 Nov 5.
Schizophrenia is a heterogeneous disease generally considered to result from a combination of heritable and environmental factors. Although its pathophysiology has not been fully determined, biological studies support the involvement of several possible components including altered DNA methylation, abnormal glutamatergic transmission, altered mitochondrial function, folate deficiency and high maternal homocysteine levels. Although these factors have been explored separately, they all involve one-carbon (C1) metabolism. Furthermore, C1 metabolism is well positioned to integrate gene-environment interactions by influencing epigenetic regulation. Here, we discuss the potential roles of C1 metabolism in the pathophysiology of schizophrenia. Understanding the contribution of these mechanisms could yield new therapeutic approaches aiming to counteract disease onset or progression.
精神分裂症是一种异质性疾病,通常被认为是遗传和环境因素共同作用的结果。尽管其病理生理学尚未完全确定,但生物学研究支持多种可能成分的参与,包括 DNA 甲基化改变、谷氨酸能传递异常、线粒体功能改变、叶酸缺乏和高同型半胱氨酸血症。虽然这些因素已经分别进行了探讨,但它们都涉及到一碳(C1)代谢。此外,C1 代谢通过影响表观遗传调控,很好地整合了基因-环境相互作用。在这里,我们讨论了 C1 代谢在精神分裂症病理生理学中的潜在作用。了解这些机制的贡献可能会产生新的治疗方法,旨在对抗疾病的发生或进展。